Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy.
about
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database.Life-threatening dermatologic adverse events in oncologyAnticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.
P2860
Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Toxic epidermal necrolysis in ...... receiving thalidomide therapy.
@en
Toxic epidermal necrolysis in ...... receiving thalidomide therapy.
@nl
type
label
Toxic epidermal necrolysis in ...... receiving thalidomide therapy.
@en
Toxic epidermal necrolysis in ...... receiving thalidomide therapy.
@nl
prefLabel
Toxic epidermal necrolysis in ...... receiving thalidomide therapy.
@en
Toxic epidermal necrolysis in ...... receiving thalidomide therapy.
@nl
P2093
P1476
Toxic epidermal necrolysis in ...... receiving thalidomide therapy.
@en
P2093
Antonio Tabilio
Gino Coletti
Lorenzo Moretti
Marianna Colagrande
Mario Lapecorella
Mauro Di Ianni
P2888
P356
10.1007/S12185-008-0220-2
P577
2008-12-04T00:00:00Z